what amino acids are in bpc 157 Predicted three-dimensional structure of BPC-157. (Top panel) Predicted BPC-157: Tendon Repair and More

These are starting points, not rigid rules

Yuan et al., 2009)

Phase 2 failed primary endpoint Attribute Unique advantage SLU-PP-332 Only pan-ERR agonist with demonstrated in-vivo exercise-mimetic activity MOTS-c Endogenous mitochondrial peptide with AMPK-focused signaling AOD-9604 Most human clinical history of the three Half-life and dose figures across the three compounds are mostly from animal data and should not be read as validated human pharmacology

While more severe forms are not all that common, some research estimates that MCAS could affect up to 17% of the population on a spectrum from very mild to debilitating symptoms.[ref] Others include very mild symptoms such as allergic rhinitis in the mast cell activation spectrum, which includes up to 30% of the population.[ref]